Industry News

CytomX Therapeutics and ImmunoGen announce collaboration to develop probody-drug conjugate therapies for the treatment of cancer.

Eurofins acquires DDS business of Merck KGaA in order to expand discovery solutions and bioanalytical services.

LSNE completes an FDA inspection of its Manchester manufacturing facility.Lyophilization Services of New England (LSNE),

Genzyme plans to appeal FDA?s decision that the multiple-sclerosis treatment is not ready for approval.

Baxter International recalls dextrose injection and four sodium chloride injections.

Pall Corporation, a solutions provider in filtration, separation and purification, has signed a definitive agreement with ATMI to acquire ATMI's LifeSciences business unit for $185 million.

Merck and GlaxoSmithKline begin clinical trial of pazopanib for the treatment of advanced renal-cell carcinoma.

Bind Therapeutics amends its development and commercialization collaboration agreement with Amgen.

CMC Biologics and OnoSynergy form an agreement from cell-line development.

Leidos Holdings awards Pfenex a subcontract in support of the development of an anthrax vaccine.

Siemens enters agreement with Pfizer to commercialize diagnostic tests for therapeutic products across Pfizer's pipeline.

ProBioGen signs agreement with Emergent BioSolutions for access to ProBioGen's avian AGE1.CR cell line.

Almost 400 new medicines for infectious diseases, including viral infections, bacterial infections, fungal infections and parasitic infections.

Johnson&Johnson will open a network of partnering offices across the UK.

BioWa and Lonza have entered into a licensing agreement with MedImmune for cell line technology.

Octapharma and Pfizer form an agreement for the future marketing and commercialization of human prothrombin complex concentrate.

GSK forms the Oncology Clinical and Translational Consortium, a scientific research network comprised of six international cancer centers.

Bristol-Myers Squibb has elected Thomas Lynch, Jr., MD to its board of directors.

LSNE appoints Shawn Cain as COO, a new position within the company.

TxCell has received manufacturing accreditation status of its cell-therapy production site in Besancon, France, from the French National Agency for Drug Safety (ANSM).

SGS Life Science Services announced that its bioanalytical laboratory in Poitiers, France has received GMP certification, following approval from ANSM.

Almac releases an enhanced third-party logistics customer billing application.

GSK and Amicus Therapeutics revise Fabry agreement entered into in July 2012.

Coldstream Laboratories names director of formulation development.

Pure MHC and Catalent sign an agreement to develop RL21A using Catalent's GPEx technology.

Catalent opens clinical-trial supply facility in Shanghai, China.

Catalent has signed a product development agreement with immunology company Pure MHC (major histocompatibility complex), which specializes in MHC-based diagnostics and therapeutics.

Covance Inc. and Pathoquest have announced a collaboration to provide next-generation sequencing based biosafety assessments to detect and identify viral contaminants within biologic compounds.